Clinical and mutational spectrum of highly differentiated, PAX:FOXO1 fusion-negative rhabdomyosarcoma – a report from the Children’s Oncology Group
2018
Background
Pediatric PAX:FOXO1 fusion-negative rhabdomyosarcoma represents a diverse spectrum of tumors with marked differences in histology, myogenic differentiation and clinical behavior.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI